Showing results (51-60 of 1,150) with videos related to
Sort By:
Pageof 115
Expert Opinion on Therapeutic Targets|October 20, 2010
Oxidative pathways as a drug target for the treatment of autismKristi-Ann Villagonzalo, Seetal Dodd, Olivia Dean, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 27, 2012
Putative neuroprotective agents in neuropsychiatric disordersSeetal Dodd, Michael Maes, George Anderson, et al.Journal of Psychosomatic Research|June 5, 2012
Pain and the relationship with mood and anxiety disorders and psychological symptomsLana J Williams, Julie A Pasco, Felice N Jacka, et al.International Journal of Psychiatry in Clinical Practice|June 13, 2014
The utility of the Mood Disorders Questionnaire as a screening tool in a methadone maintenance treatment programKristi-Ann Villagonzalo, Seetal Dodd, Felicity Ng, et al.Acta Neuropsychiatrica|September 8, 2023
Psychiatric sequelae after SARS-Cov-2 infection: trajectory, predictors and associations in a longitudinal Australian cohortSeetal Dodd, Mohammedreza Mohebbi, Josie O'Donohue, et al.Journal of Evaluation in Clinical Practice|May 9, 2008
The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical useMichael Berk, Felicity Ng, Seetal Dodd, et al.The International Journal of Neuropsychopharmacology|February 10, 2022
Effect of Glucocorticoid and 11β-Hydroxysteroid-Dehydrogenase Type 1 (11β-HSD1) in Neurological and Psychiatric DisordersSeetal Dodd, David R Skvarc, Olivia M Dean, et al.Journal of Affective Disorders|August 27, 2018
A review of the neurobiological underpinning of comorbid substance use and mood disordersNieves Gómez-Coronado, Rickinder Sethi, Chiara Cristina Bortolasci, et al.Australian Health Review : a Publication of the Australian Hospital Association|November 27, 2010
A qualitative evaluation of a regional Early Psychosis Service 3 years after its commencementThomas Callaly, Carmel A Ackerly, Mary E Hyland, et al.Acta Neuropsychiatrica|March 9, 2016
The validity and internal structure of the Bipolar Depression Rating Scale: data from a clinical trial of N-acetylcysteine as adjunctive therapy in bipolar disorderMichael Berk, Seetal Dodd, Olivia M Dean, et al.Pageof 115